| AG-IRBESARTAN (75 MG) | 02548216 | Marketed | Angita Pharma Inc. | Mar 2025 |
| AG-IRBESARTAN (150 MG) | 02548224 | Marketed | Angita Pharma Inc. | Feb 2025 |
| AG-IRBESARTAN (300 MG) | 02548232 | Marketed | Angita Pharma Inc. | Feb 2025 |
| AVALIDE (150 MG) | 02241818 | Marketed | Sanofi-Aventis Canada Inc. | Jun 2007 |
| AVALIDE (300 MG) | 02241819 | Marketed | Sanofi-Aventis Canada Inc. | May 2007 |
| AVAPRO (150 MG) | 02237924 | Marketed | Sanofi-Aventis Canada Inc. | May 2007 |
| AVAPRO (300 MG) | 02237925 | Marketed | Sanofi-Aventis Canada Inc. | May 2007 |
| IRBESARTAN (75 MG) | 02372347 | Marketed | Sanis Health Inc. | Nov 2025 |
| IRBESARTAN (150 MG) | 02372371 | Marketed | Sanis Health Inc. | Jul 2024 |
| IRBESARTAN (300 MG) | 02372398 | Marketed | Sanis Health Inc. | Nov 2025 |
| IRBESARTAN (75 MG) | 02385287 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2012 |
| IRBESARTAN (150 MG) | 02385295 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2012 |
| IRBESARTAN (300 MG) | 02385309 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2012 |
| IRBESARTAN HCT (150 MG) | 02385317 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2012 |
| IRBESARTAN HCT (300 MG) | 02385325 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2012 |
| IRBESARTAN HCT (300 MG) | 02385333 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2012 |
| JAMP IRBESARTAN (75 MG) | 02545225 | Marketed | JAMP Pharma Corporation | Feb 2025 |
| JAMP IRBESARTAN (150 MG) | 02545233 | Marketed | JAMP Pharma Corporation | Feb 2025 |
| JAMP IRBESARTAN (300 MG) | 02545241 | Marketed | JAMP Pharma Corporation | Feb 2025 |
| M-IRBESARTAN (75 MG) | 02524813 | Marketed | Mantra Pharma Inc. | Jul 2026 |
| M-IRBESARTAN (150 MG) | 02524821 | Marketed | Mantra Pharma Inc. | Jul 2026 |
| M-IRBESARTAN (300 MG) | 02524848 | Marketed | Mantra Pharma Inc. | Jul 2026 |
| MINT-IRBESARTAN (75 MG) | 02422980 | Marketed | Mint Pharmaceuticals Inc | May 2021 |
| MINT-IRBESARTAN (150 MG) | 02422999 | Marketed | Mint Pharmaceuticals Inc | Apr 2021 |
| MINT-IRBESARTAN (300 MG) | 02423006 | Marketed | Mint Pharmaceuticals Inc | Apr 2021 |
| NB-IRBESARTAN (75 MG) | 02560070 | Marketed | NB Pharma Inc. | Apr 2026 |
| NB-IRBESARTAN (150 MG) | 02560089 | Marketed | NB Pharma Inc. | Apr 2026 |
| NB-IRBESARTAN (300 MG) | 02560097 | Marketed | NB Pharma Inc. | Apr 2026 |
| PMS-IRBESARTAN (75 MG) | 02317060 | Marketed | Pharmascience Inc. | Mar 2011 |
| PMS-IRBESARTAN (150 MG) | 02317079 | Marketed | Pharmascience Inc. | Mar 2011 |
| PMS-IRBESARTAN (300 MG) | 02317087 | Marketed | Pharmascience Inc. | Mar 2011 |
| PMS-IRBESARTAN-HCTZ (150 MG) | 02328518 | Marketed | Pharmascience Inc. | Mar 2011 |
| PMS-IRBESARTAN-HCTZ (300 MG) | 02328526 | Marketed | Pharmascience Inc. | Mar 2011 |
| PMS-IRBESARTAN-HCTZ (300 MG) | 02328534 | Marketed | Pharmascience Inc. | Mar 2011 |
| PRO-IRBESARTAN (75 MG) | 02365197 | Marketed | Pro Doc Limitee | Jul 2026 |
| PRO-IRBESARTAN (150 MG) | 02365200 | Marketed | Pro Doc Limitee | Jul 2026 |
| PRO-IRBESARTAN (300 MG) | 02365219 | Marketed | Pro Doc Limitee | Jul 2026 |
| PRO-IRBESARTAN-HCTZ (150 MG) | 02365162 | Marketed | Pro Doc Limitee | Mar 2026 |
| PRO-IRBESARTAN-HCTZ (300 MG) | 02365170 | Marketed | Pro Doc Limitee | Mar 2026 |
| PRO-IRBESARTAN-HCTZ (300 MG) | 02365189 | Marketed | Pro Doc Limitee | Mar 2026 |
| RIVA-IRBESARTAN (75 MG) | 02524732 | Marketed | Laboratoire Riva Inc. | Jun 2023 |
| RIVA-IRBESARTAN (150 MG) | 02524740 | Marketed | Laboratoire Riva Inc. | Jun 2023 |
| RIVA-IRBESARTAN (300 MG) | 02524759 | Marketed | Laboratoire Riva Inc. | Jun 2023 |
| SANDOZ IRBESARTAN (75 MG) | 02328461 | Marketed | Sandoz Canada Inc. | Mar 2011 |
| SANDOZ IRBESARTAN (150 MG) | 02328488 | Marketed | Sandoz Canada Inc. | Mar 2011 |
| SANDOZ IRBESARTAN (300 MG) | 02328496 | Marketed | Sandoz Canada Inc. | Mar 2011 |
| SANDOZ IRBESARTAN HCT (150 MG) | 02337428 | Marketed | Sandoz Canada Inc. | Mar 2011 |
| SANDOZ IRBESARTAN HCT (300 MG) | 02337436 | Marketed | Sandoz Canada Inc. | Mar 2011 |
| SANDOZ IRBESARTAN HCT (300 MG) | 02337444 | Marketed | Sandoz Canada Inc. | Mar 2011 |
| SPC-IRBESARTAN (75 MG) | 02406810 | Marketed | Sun Pharma Canada Inc. | Jun 2026 |
| SPC-IRBESARTAN (150 MG) | 02406829 | Marketed | Sun Pharma Canada Inc. | Jun 2026 |
| SPC-IRBESARTAN (300 MG) | 02406837 | Marketed | Sun Pharma Canada Inc. | Jun 2026 |
| TEVA-IRBESARTAN HCTZ (150 MG) | 02330512 | Marketed | Teva Canada Limited | Jun 2018 |
| TEVA-IRBESARTAN HCTZ (300 MG) | 02330520 | Marketed | Teva Canada Limited | Jun 2018 |
| TEVA-IRBESARTAN HCTZ (300 MG) | 02330539 | Marketed | Teva Canada Limited | Jun 2018 |
| APO-IRBESARTAN (75 MG) | 02386968 | Dormant | Apotex Inc. | Nov 2019 |
| APO-IRBESARTAN (150 MG) | 02386976 | Dormant | Apotex Inc. | Dec 2019 |
| APO-IRBESARTAN (300 MG) | 02386984 | Dormant | Apotex Inc. | Nov 2019 |
| APO-IRBESARTAN/HCTZ (150 MG) | 02387646 | Dormant | Apotex Inc. | May 2019 |
| APO-IRBESARTAN/HCTZ (300 MG) | 02387654 | Dormant | Apotex Inc. | May 2019 |
| APO-IRBESARTAN/HCTZ (300 MG) | 02387662 | Dormant | Apotex Inc. | Aug 2019 |
| AURO-IRBESARTAN (75 MG) | 02406098 | Dormant | Auro Pharma Inc. | Jul 2020 |
| AURO-IRBESARTAN (150 MG) | 02406101 | Dormant | Auro Pharma Inc. | Jul 2020 |
| AURO-IRBESARTAN (300 MG) | 02406128 | Dormant | Auro Pharma Inc. | Jul 2020 |
| AURO-IRBESARTAN HCT (150 MG) | 02447878 | Dormant | Auro Pharma Inc. | Jul 2020 |
| AURO-IRBESARTAN HCT (300 MG) | 02447886 | Dormant | Auro Pharma Inc. | Jul 2020 |
| AURO-IRBESARTAN HCT (300 MG) | 02447894 | Dormant | Auro Pharma Inc. | Jul 2020 |
| IRBESARTAN (75 MG) | 02396017 | Approved | Jubilant Generics Limited | Oct 2012 |
| IRBESARTAN (150 MG) | 02396025 | Approved | Jubilant Generics Limited | Oct 2012 |
| IRBESARTAN (300 MG) | 02396033 | Approved | Jubilant Generics Limited | Oct 2012 |
| IRBESARTAN AND HYDROCHLOROTHIAZIDE (150 MG) | 02404001 | Approved | Jubilant Generics Limited | Mar 2013 |
| IRBESARTAN AND HYDROCHLOROTHIAZIDE (300 MG) | 02404028 | Approved | Jubilant Generics Limited | Mar 2013 |
| IRBESARTAN AND HYDROCHLOROTHIAZIDE (300 MG) | 02404036 | Approved | Jubilant Generics Limited | Mar 2013 |
| IRBESARTAN/HCTZ (150 MG) | 02372886 | Dormant | Sanis Health Inc. | Jul 2026 |
| IRBESARTAN/HCTZ (300 MG) | 02372894 | Dormant | Sanis Health Inc. | Jul 2026 |
| IRBESARTAN/HCTZ (300 MG) | 02372908 | Dormant | Sanis Health Inc. | Jul 2026 |
| NB-IRBESARTAN HCT (150 MG) | 02570211 | Approved | NB Pharma Inc. | Jul 2026 |
| NB-IRBESARTAN HCT (300 MG) | 02570238 | Approved | NB Pharma Inc. | Jul 2026 |
| NB-IRBESARTAN HCT (300 MG) | 02570246 | Approved | NB Pharma Inc. | Jul 2026 |
| PENDO-IRBESARTAN (300 MG) | 02427222 | Approved | Pendopharm Division Of Pharmascience Inc | Jul 2014 |
| PENDO-IRBESARTAN-HCTZ (300 MG) | 02427214 | Approved | Pendopharm Division Of Pharmascience Inc | Jul 2014 |
| ACT IRBESARTAN (75 MG) | 02328070 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT IRBESARTAN (150 MG) | 02328089 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT IRBESARTAN (300 MG) | 02328100 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT IRBESARTAN/HCT (150 MG) | 02357399 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT IRBESARTAN/HCT (300 MG) | 02357402 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT IRBESARTAN/HCT (300 MG) | 02357410 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| AG-IRBESARTAN (75 MG) | 02474395 | Cancelled Post Market | Angita Pharma Inc. | Sep 2022 |
| AG-IRBESARTAN (150 MG) | 02474409 | Cancelled Post Market | Angita Pharma Inc. | Sep 2022 |
| AG-IRBESARTAN (300 MG) | 02474417 | Cancelled Post Market | Angita Pharma Inc. | Sep 2022 |
| AG-IRBESARTAN HCTZ (150 MG) | 02476428 | Cancelled Post Market | Angita Pharma Inc. | Sep 2022 |
| AG-IRBESARTAN HCTZ (300 MG) | 02476444 | Cancelled Post Market | Angita Pharma Inc. | Sep 2022 |
| AG-IRBESARTAN HCTZ (300 MG) | 02476436 | Cancelled Post Market | Angita Pharma Inc. | Sep 2022 |
| AVA-IRBESARTAN (75 MG) | 02373319 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AVA-IRBESARTAN (150 MG) | 02373327 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AVA-IRBESARTAN (300 MG) | 02373335 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AVA-IRBESARTAN/HCTZ (150 MG) | 02373343 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AVA-IRBESARTAN/HCTZ (300 MG) | 02373351 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AVA-IRBESARTAN/HCTZ (300 MG) | 02373378 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AVALIDE (300 MG) | 02280213 | Cancelled Post Market | Sanofi-Aventis Canada Inc. | Jul 2017 |
| AVAPRO (75 MG) | 02237923 | Cancelled Post Market | Sanofi-Aventis Canada Inc. | Jan 2025 |
| BIO-IRBESARTAN (75 MG) | 02446146 | Cancelled Post Market | Biomed Pharma | Jul 2022 |
| BIO-IRBESARTAN (150 MG) | 02446154 | Cancelled Post Market | Biomed Pharma | Jul 2022 |
| BIO-IRBESARTAN (300 MG) | 02446162 | Cancelled Post Market | Biomed Pharma | Jul 2022 |
| DOM-IRBESARTAN (75 MG) | 02372185 | Cancelled Pre Market | Dominion Pharmacal | Feb 2019 |
| DOM-IRBESARTAN (150 MG) | 02372193 | Cancelled Post Market | Dominion Pharmacal | Feb 2019 |
| DOM-IRBESARTAN (300 MG) | 02372207 | Cancelled Pre Market | Dominion Pharmacal | Feb 2019 |
| DOM-IRBESARTAN-HCTZ (150 MG) | 02372223 | Cancelled Pre Market | Dominion Pharmacal | Feb 2019 |
| DOM-IRBESARTAN-HCTZ (300 MG) | 02372231 | Cancelled Pre Market | Dominion Pharmacal | Feb 2019 |
| DOM-IRBESARTAN-HCTZ (300 MG) | 02372266 | Cancelled Pre Market | Dominion Pharmacal | Feb 2019 |
| IPG-IRBESARTAN (75 MG) | 02435438 | Cancelled Pre Market | Marcan Pharmaceuticals Inc. | Jul 2026 |
| IPG-IRBESARTAN (150 MG) | 02435446 | Cancelled Pre Market | Marcan Pharmaceuticals Inc. | Jul 2026 |
| IPG-IRBESARTAN (300 MG) | 02435454 | Cancelled Pre Market | Marcan Pharmaceuticals Inc. | Jul 2026 |
| IRBESARTAN (75 MG) | 02414635 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2025 |
| IRBESARTAN (150 MG) | 02414643 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2025 |
| IRBESARTAN (300 MG) | 02414651 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2025 |
| IRBESARTAN (75 MG) | 02433826 | Cancelled Pre Market | Actavis Pharma Company | Sep 2017 |
| IRBESARTAN (150 MG) | 02433834 | Cancelled Pre Market | Actavis Pharma Company | Sep 2017 |
| IRBESARTAN (300 MG) | 02433842 | Cancelled Pre Market | Actavis Pharma Company | Sep 2017 |
| IRBESARTAN/HCT (150 MG) | 02434261 | Cancelled Pre Market | Actavis Pharma Company | Sep 2017 |
| IRBESARTAN/HCT (300 MG) | 02434288 | Cancelled Pre Market | Actavis Pharma Company | Sep 2017 |
| IRBESARTAN/HCT (300 MG) | 02434296 | Cancelled Pre Market | Actavis Pharma Company | Sep 2017 |
| JAMP-IRBESARTAN (75 MG) | 02418193 | Cancelled Post Market | JAMP Pharma Corporation | Sep 2022 |
| JAMP-IRBESARTAN (150 MG) | 02418207 | Cancelled Post Market | JAMP Pharma Corporation | Sep 2022 |
| JAMP-IRBESARTAN (300 MG) | 02418215 | Cancelled Post Market | JAMP Pharma Corporation | Sep 2022 |
| JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE (150 MG) | 02418223 | Cancelled Post Market | JAMP Pharma Corporation | Sep 2022 |
| JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE (300 MG) | 02418231 | Cancelled Post Market | JAMP Pharma Corporation | Sep 2022 |
| JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE (300 MG) | 02418258 | Cancelled Post Market | JAMP Pharma Corporation | Sep 2022 |
| MAR-IRBESARTAN (75 MG) | 02436108 | Cancelled Pre Market | Marcan Pharmaceuticals Inc. | Aug 2026 |
| MAR-IRBESARTAN (150 MG) | 02436116 | Cancelled Pre Market | Marcan Pharmaceuticals Inc. | Aug 2026 |
| MAR-IRBESARTAN (300 MG) | 02436124 | Cancelled Pre Market | Marcan Pharmaceuticals Inc. | Aug 2026 |
| MINT-IRBESARTAN/HCTZ (150 MG) | 02392992 | Cancelled Post Market | Mint Pharmaceuticals Inc | Jul 2020 |
| MINT-IRBESARTAN/HCTZ (300 MG) | 02393018 | Cancelled Post Market | Mint Pharmaceuticals Inc | Jul 2020 |
| MINT-IRBESARTAN/HCTZ (300 MG) | 02393026 | Cancelled Post Market | Mint Pharmaceuticals Inc | Jul 2020 |
| MYLAN-IRBESARTAN (75 MG) | 02347296 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Aug 2018 |
| MYLAN-IRBESARTAN (150 MG) | 02347318 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Aug 2018 |
| MYLAN-IRBESARTAN (300 MG) | 02347326 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Oct 2017 |
| MYLAN-IRBESARTAN HCTZ (150 MG) | 02376873 | Cancelled Pre Market | Mylan Pharmaceuticals Ulc | Nov 2016 |
| MYLAN-IRBESARTAN HCTZ (300 MG) | 02376881 | Cancelled Pre Market | Mylan Pharmaceuticals Ulc | Nov 2016 |
| MYLAN-IRBESARTAN HCTZ (300 MG) | 02376903 | Cancelled Pre Market | Mylan Pharmaceuticals Ulc | Nov 2016 |
| NTP-IRBESARTAN (75 MG) | 02368978 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-IRBESARTAN (150 MG) | 02368986 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-IRBESARTAN (300 MG) | 02368994 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-IRBESARTAN/HCTZ (150 MG) | 02368935 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-IRBESARTAN/HCTZ (300 MG) | 02368943 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-IRBESARTAN/HCTZ (300 MG) | 02368951 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| PRIVA-IRBESARTAN (75 MG) | 02446499 | Cancelled Post Market | Pharmapar Inc. | Jul 2022 |
| PRIVA-IRBESARTAN (150 MG) | 02446502 | Cancelled Post Market | Pharmapar Inc. | Jul 2022 |
| PRIVA-IRBESARTAN (300 MG) | 02446510 | Cancelled Post Market | Pharmapar Inc. | Jul 2022 |
| Q-IRBESARTAN (75 MG) | 02393514 | Cancelled Pre Market | Qd Pharmaceuticals Ulc | Aug 2015 |
| Q-IRBESARTAN (150 MG) | 02393522 | Cancelled Pre Market | Qd Pharmaceuticals Ulc | Aug 2015 |
| Q-IRBESARTAN (300 MG) | 02393530 | Cancelled Pre Market | Qd Pharmaceuticals Ulc | Aug 2015 |
| RAN-IRBESARTAN HCTZ (150 MG) | 02363208 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2022 |
| RAN-IRBESARTAN HCTZ (300 MG) | 02363216 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2022 |
| RAN-IRBESARTAN HCTZ (300 MG) | 02363224 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2022 |
| RIVA-IRBESARTAN (75 MG) | 02425319 | Cancelled Post Market | Laboratoire Riva Inc. | Apr 2019 |
| RIVA-IRBESARTAN (150 MG) | 02425327 | Cancelled Post Market | Laboratoire Riva Inc. | Apr 2019 |
| RIVA-IRBESARTAN (300 MG) | 02425335 | Cancelled Post Market | Laboratoire Riva Inc. | Apr 2019 |
| TEVA-IRBESARTAN (75 MG) | 02315971 | Cancelled Post Market | Teva Canada Limited | Apr 2018 |
| TEVA-IRBESARTAN (150 MG) | 02315998 | Cancelled Post Market | Teva Canada Limited | Apr 2018 |
| TEVA-IRBESARTAN (300 MG) | 02316005 | Cancelled Post Market | Teva Canada Limited | Apr 2018 |
| TEVA-IRBESARTAN (75 MG) | 02316390 | Cancelled Post Market | Teva Canada Limited | Feb 2024 |
| TEVA-IRBESARTAN (150 MG) | 02316404 | Cancelled Post Market | Teva Canada Limited | Apr 2025 |
| TEVA-IRBESARTAN (300 MG) | 02316412 | Cancelled Post Market | Teva Canada Limited | May 2025 |
| TEVA-IRBESARTAN/HCTZ (150 MG) | 02316013 | Cancelled Post Market | Teva Canada Limited | Apr 2018 |
| TEVA-IRBESARTAN/HCTZ (300 MG) | 02316021 | Cancelled Post Market | Teva Canada Limited | Apr 2018 |
| TEVA-IRBESARTAN/HCTZ (300 MG) | 02316048 | Cancelled Post Market | Teva Canada Limited | Apr 2018 |
| VAN-IRBESARTAN (75 MG) | 02427087 | Cancelled Post Market | Vanc Pharmaceuticals Inc | Aug 2019 |
| VAN-IRBESARTAN (150 MG) | 02427095 | Cancelled Post Market | Vanc Pharmaceuticals Inc | Aug 2019 |
| VAN-IRBESARTAN (300 MG) | 02427109 | Cancelled Post Market | Vanc Pharmaceuticals Inc | Aug 2019 |
| VAN-IRBESARTAN-HCTZ (150 MG) | 02427052 | Cancelled Pre Market | Vanc Pharmaceuticals Inc | Jul 2019 |
| VAN-IRBESARTAN-HCTZ (300 MG) | 02427060 | Cancelled Pre Market | Vanc Pharmaceuticals Inc | Jul 2019 |
| VAN-IRBESARTAN-HCTZ (300 MG) | 02427079 | Cancelled Pre Market | Vanc Pharmaceuticals Inc | Jul 2019 |